FDA drug recalls
Formal FDA enforcement reports for prescription and over-the-counter drugs — contamination, wrong potency, mislabeling, and manufacturing failures. 341 recalls in the last 12 months, in plain English.
Recent recalls
Page 6 of 12- Shimoga Chemicals clomiphene citrate recalled for cGMP deviations
Shimoga Chemicals is recalling its Clomiphene Citrate USP active pharmaceutical ingredient for cGMP deviations, which are departures from current good manufacturing practice. The product was distributed only in California and Florida. The notice reports no injuries.
ModerateFDAJul 15, 2026Shimoga Chemicals
- Somerset Therapeutics cancer drug vials recalled for lack of sterility
Reliance Life Sciences is recalling four injectable cancer drugs made for Somerset Therapeutics: Pemetrexed for Injection 100 mg and 500 mg vials, Bortezomib for Injection 3.5 mg vials, and Azacitidine for Injection 100 mg vials. The recall covers about 36,000 vials nationwide because of a lack of sterility assurance. No injuries have been reported.
ModerateFDAJul 15, 2026Reliance Life Sciences4 products
- Gasco and Drogueria San Juan isopropyl alcohol recalled for subpotency
Gasco Industrial is recalling six isopropyl alcohol 70% products sold under the Gasco and Drogueria San Juan Puerto Rico names, in 16 oz, 32 oz and 1 gallon sizes. The FDA classifies the problem as subpotency, meaning the product contains less of its labeled active ingredient than stated. The notice reports no injuries.
ModerateFDAJul 15, 2026Gasco Industrial6 products
- QuVa Pharma methohexital recalled for failed impurity specifications
QuVa Pharma is recalling certain lots of its compounded methohexital sodium 100 mg/10 mL (10 mg/mL) because they failed impurity and degradation specifications. The notice lists lot numbers with expiration dates from 07/21/2026 through 08/10/2026. No injuries have been reported.
ModerateFDAJul 15, 2026QuVa Pharma
- Medline Remedy silicone cream recalled for formaldehyde levels
Medline Remedy Specialized Silicone Cream (Hydraguard-D) failed impurities and degradation specifications because formaldehyde levels exceeded specification. About 509,652 tubes were distributed nationwide in the US. No injuries have been reported.
ModerateFDAJul 15, 2026BioMed Laboratories
- OneSource methohexital sodium recalled for failed impurity specifications
OneSource Specialty Pharma Limited is recalling one lot of Methohexital Sodium for Injection, USP 500 mg multiple dose vials, manufactured for Avet Pharmaceuticals Inc. The product failed impurities and degradation specifications. The notice reports 4,284 vials distributed nationwide and no injuries.
ModerateFDAJul 15, 2026OneSource Specialty Pharma
- McKesson gemcitabine injection recalled for improper storage temperature
One lot of McKesson gemcitabine injection, a single-dose vial for intravenous infusion, was stored at controlled room temperature instead of in a refrigerator. The recall covers 74 units of lot CB0046. No injuries have been reported.
ModerateFDAJul 8, 2026McKesson
- Revitaderm, Terpenicol and more recalled for microbial contamination
Eight Blaine Labs and Trifluent Pharma wound care and antifungal products are recalled: Revitaderm, TRIDERGEL, TRIPENICOL S, TERPENICOL, vite20, Fungal Fusion and Revitaderm First Aid Antiseptic Gel. Samples of these non-sterile products showed Lysinibacillus fusiformis and other Bacillus species. The FDA has classified this as a Class I recall.
SeriousFDAJul 8, 2026Blaine Labs8 products
- Cipla Cinacalcet tablets recalled for impurity risk
Cipla USA is recalling specific lots of Cinacalcet Hydrochloride 30 mg tablets because they contain elevated levels of N-nitroso-cinacalcet, a manufacturing impurity that exceeds FDA safety limits. The affected bottles were distributed nationwide.
ModerateFDAJul 8, 2026Cipla3 products
- Lannett amphetamine extended-release capsules recalled for label mix-up
Lannett Company distributed amphetamine extended-release capsules that contained only immediate-release pellets but were labeled as extended-release. This labeling error could result in incorrect dosing and medication timing for patients who depend on the extended-release formulation.
ModerateFDAJul 8, 2026Lannett
- Accucaine and lidocaine injection recalled for sterility concerns
Asclemed USA Inc. is recalling two lidocaine HCl 1% injection products in 5 mL single-dose ampules, sold nationwide. One is sold as Accucaine kits and the other is an unbranded lidocaine injection; both were distributed by Enovachem Pharmaceuticals. The recall was issued because the products may not be sterile, and no injuries have been reported.
ModerateFDAJul 8, 2026Asclemed USA Inc.2 products
- Synjardy XR tablets recalled for manufacturing deviations
Boehringer Ingelheim Pharmaceuticals is recalling one lot of Synjardy XR 12.5/1000 mg tablets due to manufacturing quality control issues. During production, an incorrect cleaning agent was used on equipment, and required testing of that equipment was not completed before the tablets were made.
ModerateFDAJul 8, 2026Boehringer Ingelheim
- Accord levothyroxine tablets recalled for subpotency
Accord Healthcare is recalling one lot of levothyroxine sodium 300 mcg tablets because they may contain less active ingredient than labeled. This means the medication may not work as intended for patients who need it to manage thyroid conditions.
ModerateFDAJul 8, 2026Accord Healthcare
- Lupin prednisolone acetate eye drops recalled for foreign substance
Lupin Pharmaceuticals is recalling multiple lots of prednisolone acetate ophthalmic suspension 1% (an anti-inflammatory eye drop) due to the presence of a foreign substance in some bottles. The affected lots were distributed nationwide. No injuries have been reported.
ModerateFDAJul 8, 2026Lupin
- Ohm Laboratories fexofenadine tablets recalled for failed impurity specs
Sun Pharmaceutical Industries is recalling about 9,048 bottles of Fexofenadine Hydrochloride Tablets, USP 180 mg, distributed by Ohm Laboratories. The tablets failed impurities and degradation specifications. No injuries have been reported.
FDAJul 8, 2026Sun Pharmaceutical
- Accord BioPharma IMULDOSA injection recalled for sterility concerns
Accord BioPharma is recalling one lot of IMULDOSA (ustekinumab-srlf) injection due to lack of assurance that the product is sterile. The affected lot may not meet sterility standards required for injectable medications. No injuries have been reported.
ModerateFDAJul 8, 2026ACCORD BIOPHARMA INC
- BD ChloraPrep and PurPrep applicators recalled for sterility concerns
CareFusion is recalling 10 antiseptic skin prep products sold as BD ChloraPrep (Hi-Lite Orange, Clear and Scrub Teal), BD PurPrep, and ChloraPrep FREPP. Applicators that were meant to be sterilized before use were instead shipped to customers outside the intended distribution channel, so they may not be sterile. No injuries have been reported.
ModerateFDAJul 8, 2026CareFusion10 products
- Lupin Glucagon Emergency Kit recalled for plunger defect
Lupin Pharmaceuticals is recalling certain lots of its Glucagon Emergency Kit because the syringe plunger may not move smoothly during use. This defect was discovered during stability testing and could prevent the kit from working properly in an emergency.
ModerateFDAJul 8, 2026Lupin2 products
- Sun Pharmaceutical perampanel 6 mg tablets recalled for label mix-up
Sun Pharmaceutical discovered that some bottles labeled as containing 6mg Perampanel tablets actually contained 10mg tablets instead. This mix-up affects one lot (AE01763) distributed nationwide. Patients taking the wrong strength could receive an incorrect dose of this seizure medication.
ModerateFDAJul 1, 2026Sun Pharmaceutical
- Elevate Oral Care Povi-One antiseptic recalled for subpotency
Elevate Oral Care's Povi-One 10% Povidone-Iodine Oral Antiseptic does not contain the full strength stated on the label. Five specific production lots distributed nationwide do not meet the required potency standard, which means the product may not work as intended for oral antiseptic purposes.
ModerateFDAJul 1, 2026Elevate Oral Care
- Annora lacosamide tablets recalled for possible selexipag mix-up
Some bottles of Lacosamide 100mg tablets may contain Selexipag 1000 mcg tablets instead. This mix-up happened during manufacturing and could cause patients to take the wrong medication. The recall affects specific lots distributed nationwide.
ModerateFDAJul 1, 2026Annora Pharma
- BD ChloraPrep applicators recalled for sterility risk
CareFusion is recalling four sizes of BD ChloraPrep Clear and BD ChloraPrep FREPP Clear skin antiseptic applicators because wrinkles in the paper lid may break the seal, so the products may not stay sterile. No injuries have been reported. The products were distributed nationwide in the U.S. and to other countries.
ModerateFDAJul 1, 2026CareFusion4 products
- PReye Vitamin See eye drops recalled for sterility concerns
PReye LLC is recalling all lots of PReye Vitamin See Antioxidant Preservative Free Eye Drops due to lack of assurance of sterility. The recall affects approximately 50 to 60 bottles distributed in Colorado. No injuries have been reported.
ModerateFDAJul 1, 2026PReye
- ANI Pharmaceuticals hydroxyzine solution recalled for foreign substance
ANI Pharmaceuticals is recalling hydroxyzine hydrochloride oral solution (10 mg/5 mL, 473 mL bottles) due to the presence of a foreign substance in one lot. The affected product was distributed nationwide. No injuries have been reported.
ModerateFDAJul 1, 2026ANI Pharmaceuticals
- Central Admixture pediatric TPN bag missing required nutrients
Central Admixture Pharmacy Services issued a recall for one patient-specific Total Parenteral Nutrition (TPN) bag that did not contain copper and famotidine as listed on the label. The bag was prepared for a pediatric patient in Massachusetts. No injuries have been reported.
ModerateFDAJul 1, 2026Central Admixture Pharmacy Services
- Direct Rx Duloxetine D/R recalled for impurity risk
Direct Rx's packaged Duloxetine D/R 30 mg capsules contain levels of N-nitroso-duloxetine, a potentially harmful impurity, above FDA's recommended limit. This is a manufacturing quality issue affecting specific lots distributed nationwide.
ModerateFDAJul 1, 2026Direct Rx
- Amgen Corlanor and Sensipar tablets recalled for foreign substance
Amgen is recalling five bottle sizes of two prescription heart and thyroid-related drugs, Corlanor (ivabradine) and Sensipar (cinacalcet), because the tablets may contain a foreign substance. The products were distributed nationwide, and no injuries have been reported.
ModerateFDAJul 1, 2026Amgen5 products
- Ajanta Pharma fenofibrate capsules recalled for CGMP deviations
Ajanta Pharma USA Inc. is recalling one lot of fenofibrate 200 mg capsules due to manufacturing quality deviations discovered during inspection. The affected lot (PA02216, expiring 12/2029) was distributed nationwide.
ModerateFDAJul 1, 2026Ajanta Pharma
- Major Pharmaceuticals Methylergonovine Maleate recalled for subpotency
MAJOR Pharmaceuticals is recalling Methylergonovine Maleate Tablets, USP, 0.2 mg due to subpotency — meaning the tablets contain less active ingredient than labeled. The affected lots were distributed nationwide. This is a prescription medication used to control bleeding after childbirth.
ModerateFDAJul 1, 2026The Harvard Drug
- Med Pride, Lucky and more creams recalled for quality issues
Dabur is recalling 14 antibiotic and antifungal creams, ointments and first aid products, including Lucky Super Soft, Circle K, Lil Drug Store, Rapidol, Cura Hongos and Med Pride. The FDA found manufacturing quality problems (CGMP deviations) during an inspection. No injuries have been reported.
ModerateFDAJun 24, 2026Dabur14 products